Durham, NC, United States of America

Andrew B Nixon

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Duke University. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew B Nixon. Retrieved from https://idiyas.com/inventor/andrew-b-nixon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Andrew B Nixon

Introduction

Andrew B Nixon is a prominent inventor based in Durham, NC (US), known for his significant contributions to cancer research and treatment. With a total of 4 patents, Nixon has focused on developing methods that enhance the effectiveness of cancer therapies, particularly those targeting vascular endothelial growth factor (VEGF).

Latest Patents

Nixon's latest patents include groundbreaking methods for predicting the responsiveness of cancer to VEGF targeting agents. One of his notable inventions involves a process that includes obtaining a sample from a subject, determining the expression level of biomarkers such as VEGF-D and PlGF, and predicting the cancer's responsiveness to treatment. This innovative approach may also involve administering a VEGF targeting agent or chemotherapy to the subject. Another significant patent focuses on developing a prognosis for pancreatic cancer by detecting the expression levels of biomarkers like ANG-2, SDF-1, and VEGF-D. These methods aim to create tailored treatment plans based on the predicted effectiveness of the therapies.

Career Highlights

Nixon's career is marked by his dedication to advancing cancer treatment methodologies. His work at Duke University has positioned him as a key figure in the field of oncology research. His innovative approaches have the potential to significantly improve patient outcomes by personalizing cancer therapies based on individual biomarker profiles.

Collaborations

Nixon has collaborated with esteemed colleagues such as Herbert I Hurwitz and Mark D Starr, contributing to a rich environment of research and innovation. These collaborations have further enhanced the impact of his work in the medical community.

Conclusion

Andrew B Nixon's contributions to cancer treatment through his innovative patents and research at Duke University exemplify the vital role of inventors in advancing medical science. His work continues to pave the way for more effective cancer therapies, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…